NeoGenomics, Inc.’s NEO share price has dipped by 10.05%, which has investors questioning if this is right time to buy.

Bank of New York Mellon Corp lifted its position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 1.8% during the 4th ...

Neo Performance Materials is poised to benefit from the renewable and EV transitions, with its rare earth metals being ...

Keybank National Association OH lifted its stake in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 22.2% in the 4th quarter, ...

As I like to say, "A company's long-term stock price growth is based on its financial growth." Therefore, first let's take a look at pillars 3, 4 and 5. Over the past 5Y, Neo has been growing ...

TD Cowen analyst Daniel Brennan maintained a Buy rating on NeoGenomics (NEO – Research Report) today and set a price target of $19.00. The ...

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on NeoGenomics (NEO – Research Report). The company’s shares ...

NeoGenomics (NEO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more ...

Mahindra offering discounts up to Rs 1.40 lakh on Thar, Scorpio N, Bolero, and more in March 2025. Tap for more details.

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...